A phase 1, open-label, two-period, one-sequence, crossover study to evaluate effect of Omeprazole on the pharmacokinetics, safety, and tolerability of Roxadustat in healthy subjects
Phase of Trial: Phase I
Latest Information Update: 18 May 2018
Price : $35 *
At a glance
- Drugs Roxadustat (Primary) ; Omeprazole
- Indications Anaemia
- Focus Pharmacokinetics
- Sponsors Astellas Pharma
- 18 May 2018 New trial record
- 11 May 2018 According to results presented at the European Journal of Drug Metabolism and Pharmacokinetics, the study was conducted at the single center (PAREXEL Early Phase Clinical Unit) in Berlin, Germany.
- 11 May 2018 Results assessing effect of omeprazole on pharmacokinetics, safety and tolerability of Roxadustat were published in the European Journal of Drug Metabolism and Pharmacokinetics.